Graham Capital Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,323
Closed -$123K 1475
2026
Q1
$123K Buy
+10,323
New +$148K ﹤0.01% 1019
2024
Q2
Sell
-22,814
Closed -$681K 1328
2024
Q1
$681K Buy
+22,814
New +$714K 0.01% 536
2023
Q2
Sell
-7,169
Closed -$247K 1271
2023
Q1
$247K Sell
7,169
-25,048
-78% -$813K 0.01% 920
2022
Q4
$898K Buy
+32,217
New +$853K 0.03% 572
2022
Q3
Sell
-16,302
Closed -$471K 1295
2022
Q2
$471K Buy
+16,302
New +$712K 0.02% 689

Other funds holding SGRY

Graham Capital Management's SGRY Position: Q2 2026 in Review

Graham Capital Management sold out of Surgery Partners (SGRY) in Q2 2026, closing a stake of 10,323 shares — an estimated $123K sold.

Graham Capital Management first reported a position in SGRY in Q2 2022 and held it in 5 quarters. The position peaked at $898K in Q4 2022. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Graham Capital Management reported no remaining Surgery Partners position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 10,323 Surgery Partners shares in Q2 2026, an estimated $123K.
  • Graham Capital Management first reported a position in Surgery Partners in Q2 2022 and held it in 5 quarters.
  • Graham Capital Management's Surgery Partners position peaked at $898K in Q4 2022.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.